Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115993) titled 'Safety and Efficacy of Rapid ART Initiation in Chengdu HIV Patients: A Prospective Observational Study' on Jan. 4.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Public Health Clinical Center of Chengdu
Condition:
HIV
Intervention:
Integrase Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-09
Target Sample Size: Integrase Group:100;Non-nucleoside Reverse Transcriptase Inhibitors Group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=302814
Disclaimer: Curated by HT Syndicatio...